State Street’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5M Buy
8,396,356
+6,208,185
+284% +$27.8M ﹤0.01% 1930
2025
Q4
$8.25M Buy
2,188,171
+827,257
+61% +$1.61M ﹤0.01% 2741
2025
Q3
$2.19M Buy
1,360,914
+248,209
+22% +$442K ﹤0.01% 3311
2025
Q2
$2.44M Buy
1,112,705
+835,676
+302% +$1.28M ﹤0.01% 3241
2025
Q1
$299K Buy
277,029
+49,300
+22% +$58.5K ﹤0.01% 3733
2024
Q4
$237K Buy
227,729
+53,200
+30% +$60.7K ﹤0.01% 3807
2024
Q3
$218K Buy
174,529
+40,500
+30% +$49.5K ﹤0.01% 3807
2024
Q2
$159K Buy
134,029
+36,900
+38% +$50.2K ﹤0.01% 3881
2024
Q1
$98.1K Hold
97,129
﹤0.01% 4033
2023
Q4
$103K Hold
97,129
﹤0.01% 4052
2023
Q3
$159K Hold
97,129
﹤0.01% 3993
2023
Q2
$152K Hold
97,129
﹤0.01% 4091
2023
Q1
$139K Buy
97,129
+25,400
+35% +$62.8K ﹤0.01% 4200
2022
Q4
$169K Buy
71,729
+13,523
+23% +$37.9K ﹤0.01% 4171
2022
Q3
$118K Buy
58,206
+6,970
+14% +$19.2K ﹤0.01% 4398
2022
Q2
$114K Hold
51,236
﹤0.01% 4469
2022
Q1
$342K Buy
51,236
+13,768
+37% +$80.5K ﹤0.01% 4192
2021
Q4
$207K Hold
37,468
﹤0.01% 4334
2021
Q3
$343K Hold
37,468
﹤0.01% 4126
2021
Q2
$416K Buy
+37,468
New +$366K ﹤0.01% 3928
2018
Q1
Sell
-76
Closed -$30K 3781
2017
Q4
$30K Hold
76
﹤0.01% 3667
2017
Q3
$40K Hold
76
﹤0.01% 3678
2017
Q2
$66K Sell
76
-97
-56% -$84.4K ﹤0.01% 3573
2017
Q1
$153K Buy
173
+78
+82% +$129K ﹤0.01% 3522
2016
Q4
$274K Buy
+95
New +$552K ﹤0.01% 3465

Other funds holding SLS